Abstract
Diabetic gastroparesis (DGP) is a serious and chronic complication of long-standing diabetes mellitus, which brings a heavy burden to individuals and society. Traditional Chinese medicine (TCM) is considered a complementary and alternative therapy for DGP patients. Huanglian (Coptidis Rhizoma, HL) and Banxia (Pinelliae Rhizoma, BX) combined as herb pair have been frequently used in TCM prescriptions, which can effectively treat DGP in China. In this article, a practical application of TCM network pharmacological approach was used for the research on herb pair HL-BX in the treatment of DGP. Firstly, twenty-seven potential active components of HL-BX were screened from the TCMSP database, and their potential targets were also retrieved. Then, the compound-target network and PPI network were constructed from predicted common targets, and several key targets were found based on the degree of the network. Next, GO and KEGG enrichment analyses were conducted to obtain several significantly enriched terms. Finally, the experimental verification was made. The results demonstrated that network pharmacological approach was a powerful means for identifying bioactive ingredients and mechanisms of action for TCM. Network pharmacology provided an effective strategy for TCM modern research.
Highlights
Diabetic gastroparesis (DGP) is a serious and chronic complication of diabetes characterized with the disorder of gastric motility and delayed gastric emptying in the absence of mechanical obstruction [1]
A practical application of traditional Chinese medicine (TCM) network pharmacological approach was used for the research on herb pair HL-BX in the treatment of DGP, and the results demonstrated that this approach was an effective strategy for TCM modern research
A practical application of TCM network pharmacological approach was used for the research on herb pair HLBX
Summary
Diabetic gastroparesis (DGP) is a serious and chronic complication of diabetes characterized with the disorder of gastric motility and delayed gastric emptying in the absence of mechanical obstruction [1]. The treatment of DGP is aimed at controlling high-level blood glucose and improving gastrointestinal function. It was reported that some chemical drugs, such as domperidone and metoclopramide, improved some symptoms of gastroparesis. These therapeutic drugs have shown limited efficacy but fail to stop or reverse disease progression. Adverse effects further restricted the clinical treatment of DGP [1, 3,4,5]. As a complicated disease [6], DGP may require complex therapeutic approaches such as traditional Chinese medicine (TCM)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
